Welcome to our dedicated page for Joby Aviation SEC filings (Ticker: JOBY), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Joby Aviation, Inc. filings document a public transportation company developing eVTOL aircraft and related air transportation services. Its Form 8-K reports include quarterly financial results and shareholder letters, material agreements, Regulation FD disclosures, auditor changes, and financing transactions. Capital-structure disclosures reference common stock, warrants, convertible senior notes, underwriting agreements, indentures, and secured property loans.
Proxy materials disclose annual meeting matters, board and committee governance, executive compensation, equity awards, and shareholder voting. Other filings describe subsidiaries and property transactions tied to Joby's operating footprint, along with formal exhibits such as loan agreements and auditor correspondence.
Joby Aviation (JOBY) Form 144: This notice reports a proposed sale of 12,900 common shares to be executed through Morgan Stanley Smith Barney on 09/22/2025, with an aggregate market value of $213,882.00. The shares were acquired on 09/22/2025 via exercise of stock options and paid in cash. The filing lists the total shares outstanding as 855,981,489. The filer discloses prior sales by the same account during the past three months: four transactions between 07/02/2025 and 08/25/2025 totaling 22,611 shares and gross proceeds shown for each sale. The notice contains the required representation regarding absence of undisclosed material nonpublic information and references Rule 10b5-1 sales where applicable.
Joby Aviation insider Didier Papadopoulos reported RSU vesting and subsequent sales. On 09/14/2025 he was issued 11,641 restricted stock units (RSUs) that converted into common stock, increasing his beneficial ownership to 96,594 shares. The same day the RSUs were reported as acquired at $0 per share. On 09/15/2025 he sold 5,987 shares at $14.55 and on 09/16/2025 he sold 1,979 shares at $14.22, reducing his beneficial ownership to 88,628 shares. The 09/15 sale was made under an approved 10b5-1 trading plan; some shares were sold to cover taxes due on the RSU settlement.
Joby Aviation director Paul Sciarra sold 500,001 shares of JOBY common stock on 09/15/2025 under an approved 10b5-1 trading plan adopted June 27, 2024, at a weighted average price of $14.30 per share (trades ranged $14.04–$14.95). After the sale the reporting person is shown as beneficially owning 56,328,057 shares indirectly through Sciarra Management Trust and additionally holds 139,878 shares and 50,000 shares indirectly via the Sciarra Foundation. The filing was signed by an attorney-in-fact on 09/16/2025.
Form 144 notice for Joby Aviation (JOBY) reports a proposed sale of 1,979 common shares through Morgan Stanley Smith Barney with an aggregate market value of $27,943.48. The filing lists the approximate sale date as 09/16/2025 and identifies the securities exchange as the NYSE. The shares were acquired as restricted stock units from the issuer on 09/14/2025. The filing also discloses prior sales by Didier Papadopoulos during the past three months: 5,987 shares on 09/14/2025 for $87,110.85; 5,102 shares on 07/03/2025 under a 10b5-1 plan for $52,454.17; 15,440 shares on 07/02/2025 for $151,620.80; and 4,176 shares on 06/18/2025 under a 10b5-1 plan for $36,936.72. Other standard filer contact and signature fields are present but contain no substantive additional details.
Joby Aviation insider filing: This Form 144 notifies a proposed sale of 5,987 shares of Joby Aviation common stock by an insider, representing an aggregate market value of $87,102.92 based on the filing. The shares were acquired as restricted stock units granted under the issuer's 2016 Stock Option and Grant Plan and were received and paid as compensation on 09/14/2025. The filer previously sold 29,401 shares during June–July 2025 for total gross proceeds of approximately $282,737.80. The filing names Morgan Stanley as the broker and lists the approximate sale date as 09/15/2025. The filer certifies no undisclosed material adverse information.
Joby Aviation submitted a Form 144 notifying of a proposed sale of 500,001 common shares through Morgan Stanley Smith Barney LLC on 09/15/2025 for listing on the NYSE. The filing states these shares were acquired as Founders Shares from the issuer on 11/29/2017 and match the amount reported for sale.
The filing also discloses recent 10b5-1 sales by the Sciarra Management Trust: 500,001 shares on 08/25/2025 for $7,175,881.02, 500,001 shares on 07/14/2025 for $6,187,612.38, and 333,334 shares on 06/23/2025 for $2,798,772.26. Total outstanding common shares are reported as 855,981,489, making the proposed sale a small fraction of outstanding equity.
Joby Aviation, Inc. filed two prospectus supplements that permit the resale of 49,701,790 and 5,325,585 shares of its common stock by existing holders. The 5,325,585 shares were previously issued in connection with Joby’s acquisition of the passenger segment and operations of Strata Critical Medical, Inc. (formerly Blade Air Mobility, Inc.) and related entities. The 49,701,790 shares were previously issued to Toyota Motor Corporation under an amended and restated stock purchase agreement that provides for up to 99,403,579 shares at a purchase price of $5.03 per share. Both supplements are part of Joby’s existing shelf registration statement on Form S-3.
Joby Aviation registered shares for resale by a selling stockholder and discloses capital structure, governance and contractual arrangements. The company authorized up to 2.8 billion common shares and 100 million preferred shares (par value $0.0001). Toyota agreed to purchase up to 99,403,579 shares in a two‑tranche private placement at $5.03 per share, with 49,701,790 shares issued in the first tranche for $250,000,003.70 on May 22, 2025, and a second tranche subject to closing conditions. Joby’s bylaws and charter include classified board provisions, supermajority voting (66 2/3%) for certain amendments, foreign ownership voting restrictions to comply with U.S. air carrier rules, indemnification of officers and directors, and an indemnity/notice regime under the indenture for debt securities.
Joby Aviation, Inc. files a prospectus supplement that registers resale of common stock held by a selling stockholder and describes the methods by which those shares may be sold, including public offerings, private placements, broker-dealers, block trades and derivative-related transactions. The company states its common stock trades on the NYSE under the symbol JOBY and discloses a reported price of $14.27 per share on August 28, 2025.
The supplement also discloses Joby’s authorized capitalization and governance terms, including board authority to issue preferred stock, voting rules, restrictions on non-U.S. ownership for air carrier compliance, anti-takeover provisions and indemnification for officers and directors. It discloses an August 1, 2025 Equity Purchase Agreement to acquire passenger operations from Strata Critical Medical for up to $125 million, including issuance of 5,325,585 shares as consideration and contingent earnouts tied to EBITDA and retention. The prospectus incorporates audited financial statements and states Deloitte & Touche LLP audited Joby’s financials for the periods ended December 31, 2024 and 2023.
Joby Aviation, Inc. furnished an update that it has completed the acquisition of Blade’s passenger business, as described in a press release dated August 29, 2025. The company is providing this information under a Regulation FD disclosure item, meaning it is sharing the same information with all investors at once for fairness. The press release, attached as Exhibit 99.1, contains further details about the transaction, while this report clarifies that the information is considered furnished rather than filed for securities law purposes.